Tomáš Smutný

Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating<i>Mycobacterium tuberculosis</i>

Galina Karabanovich, Júlia Zemanová, Tomáš Smutný et al. · Journal of Medicinal Chemistry · 2016 · 112 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Laminin-511 and laminin-521-based matrices for efficient hepatic specification of human pluripotent stem cells

Liisa Kanninen, Riina Harjumäki, Pasi Peltoniemi et al. · Biomaterials · 2016 · 89 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three‐Dimensional Spheroid Cultures of Primary Human Hepatocytes

Delilah Hendriks, Sabine U. Vorrink, Tomáš Smutný et al. · Clinical Pharmacology & Therapeutics · 2020 · 57 citations · Full text

Medicine, Pharmacology, Cellular Pharmacology +14

1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria

Galina Karabanovich, Jaroslav Roh, Tomáš Smutný et al. · European Journal of Medicinal Chemistry · 2014 · 53 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors

Lucie Hyršová, Alena Vanduchova, Ján Dušek et al. · Toxicology Letters · 2018 · 44 citations

Medicine, Pharmacology, Toxicology +14